Merck Wins U.S. Approval of New Type of Sleeping Pill

August 13, 2014 7:58 PM

20 0

Merck & Co. (MRK:US), the second-largest U.S. drugmaker, won approval to sell its treatment for insomnia that is viewed as a drug with fewer side effects than older pills such as Ambien.

The Food and Drug Administration cleared the sleeping pill called Belsomra in lower doses than Whitehouse Station, New Jersey-based Merck originally sought to market, according to a statement today from the agency. The drug may generate $305 million in sales in 2017, according to the average of six ...

Read more

To category page